Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)
Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) 物理性質
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
| 絵表示（GHS） |
|
| 注意喚起語 |
危険 |
| 危険有害性情報 |
| コード |
危険有害性情報 |
危険有害性クラス |
区分 |
注意喚起語 |
シンボル |
P コード |
| H301 |
飲み込むと有毒 |
急性毒性、経口 |
3 |
危険 |
|
P264, P270, P301+P310, P321, P330,P405, P501 |
|
| 注意書き |
| P264 |
取扱い後は皮膚をよく洗うこと。 |
| P264 |
取扱い後は手や顔をよく洗うこと。 |
| P270 |
この製品を使用する時に、飲食または喫煙をしないこ と。 |
| P301+P310 |
飲み込んだ場合：直ちに医師に連絡すること。 |
| P405 |
施錠して保管すること。 |
| P501 |
内容物/容器を．．．に廃棄すること。 |
|
Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) 価格
もっと(2)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01USP1225533 |
Doxepin Related Compound C ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)
Doxepin Related Compound C ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) |
4504-96-5 |
25mg |
￥289100 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
1225533 |
United States Pharmacopeia (USP) Reference Standard
Doxepin Related Compound C United States Pharmacopeia (USP) Reference Standard |
4504-96-5 |
25MG |
￥176000 |
2024-03-01 |
購入 |
Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) 化学特性,用途語,生産方法
Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) 上流と下流の製品情報
原材料
準備製品
Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) 生産企業
Global( 44)Suppliers
4504-96-5()キーワード:
- 4504-96-5
- Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)
- Doxepin related coMpound C
- N-DesMethyl (E)-Doxepin Hydrochloride
- (3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N-methylpropan-1-amine:hydrochloride
- (E)-3-Dibenz[b,e]oxepin-11(6H)-ylidene-N-methyl-1-propanamine Hydrochloride
- Doxepin Hydrochloride impurity C
- Doxepin Impurity C
- Doxepin EP Impurity C
- Doxepin Impurity 3(Doxepin EP Impurity C)
- desmethyldoxepin hydrochloride salt
- Doxepin EP Impurity C HCl
- (E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride (Doxepin Impurity)
- Doxepin EP Impurity C/ Doxepin Related Compound C (N-Desmethyl (E)-Doxepin)
- Doxepin Related Compound C ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydroch (1225533)
- Doxepin USP Related Compound C as Hydrochloride
- Doxepin Impurity 3 Hydrochloride (Doxepin EP Impurity C Hydrochloride)
- Doxepin Hydrochloride EP Impurity C as Hydrochloride
- Doxepin Hydrochloride Impurity C as Hydrochloride
- Doxepin Related Compound C USPRS
- Doxepin EP Impurity C HCl ((E)-Doxepin USP Related Compound C)
- Doxepin Related Compound C ((E-3-(dibenzo[be]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)
- 1-Propanamine,?3-dibenz[b,e]oxepin-11(6H)-ylidene-N-methyl-,?hydrochloride?(1:1),?(3E)-